atenolol has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 15 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 13 patients, affected by hypertrophic obstructive cardiomyopathy (HOCM) and essential hypertension, antihypertensive-efficacy and effects of a new calcium-channel blocker (gallopamil) associated with a diuretic agent (chlorthalidone) on left ventricular systolic and diastolic performance assessed by phonocardiographic methods." | 7.67 | [Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle ( Brandini, V; Chieppa, S; De Simone, R; Giuliani, F; Iarussi, D; Langella, S; Lobascio, C, 1989) |
| "In 13 patients, affected by hypertrophic obstructive cardiomyopathy (HOCM) and essential hypertension, antihypertensive-efficacy and effects of a new calcium-channel blocker (gallopamil) associated with a diuretic agent (chlorthalidone) on left ventricular systolic and diastolic performance assessed by phonocardiographic methods." | 3.67 | [Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle ( Brandini, V; Chieppa, S; De Simone, R; Giuliani, F; Iarussi, D; Langella, S; Lobascio, C, 1989) |
| "This study failed to identify an effect of subclinical HCM on owner-assessed QOL or activity or a treatment effect of atenolol on these variables at the dosage evaluated." | 2.94 | Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers. ( Atkins, CE; Coleman, AE; DeFrancesco, TC; Griffiths, EH; Keene, BW; Kleisch, DJ; Lascelles, BDX, 2020) |
| "Two patients with hypertrophic cardiomyopathy are reported from the recent experience of the Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, demonstrating limitations in the risk stratification algorithm currently used for this disease." | 1.35 | Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. ( Appelbaum, E; Haas, TS; Harrigan, CJ; Hauser, RG; Lesser, JR; Main, ML; Maron, BJ; Maron, MS; Roberts, WC, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sugimoto, K | 1 |
| Aoki, T | 1 |
| Fujii, Y | 1 |
| Coleman, AE | 1 |
| DeFrancesco, TC | 1 |
| Griffiths, EH | 1 |
| Lascelles, BDX | 1 |
| Kleisch, DJ | 1 |
| Atkins, CE | 1 |
| Keene, BW | 1 |
| Schober, KE | 1 |
| Zientek, J | 1 |
| Li, X | 1 |
| Fuentes, VL | 1 |
| Bonagura, JD | 1 |
| White, AJ | 1 |
| Jackson, BL | 1 |
| Adin, DB | 1 |
| Lehmkuhl, LB | 1 |
| Kubo, T | 1 |
| Kitaoka, H | 1 |
| Terauchi, Y | 1 |
| Tamura, S | 1 |
| Okawa, M | 1 |
| Yamasaki, N | 1 |
| Yabe, T | 1 |
| Doi, YL | 1 |
| Comella, A | 1 |
| Magnacca, M | 1 |
| Gistri, R | 1 |
| Lombardi, M | 1 |
| Neglia, D | 1 |
| Poddighe, R | 1 |
| Pesola, A | 1 |
| Maron, BJ | 1 |
| Maron, MS | 1 |
| Lesser, JR | 1 |
| Hauser, RG | 1 |
| Haas, TS | 1 |
| Harrigan, CJ | 1 |
| Appelbaum, E | 1 |
| Main, ML | 1 |
| Roberts, WC | 1 |
| Alessandrini, RS | 1 |
| McPherson, DD | 1 |
| Kadish, AH | 1 |
| Kane, BJ | 1 |
| Goldberger, JJ | 1 |
| Rentoukas, EI | 1 |
| Deftereos, SG | 1 |
| Alpert, MA | 1 |
| Nikas, DJ | 1 |
| Lazaros, GA | 1 |
| Petropoulou, EN | 1 |
| Zacharoulis, AA | 1 |
| Gilligan, DM | 1 |
| Chan, WL | 1 |
| Stewart, R | 1 |
| Oakley, CM | 1 |
| Chieppa, S | 1 |
| Lobascio, C | 1 |
| Brandini, V | 1 |
| Iarussi, D | 1 |
| Giuliani, F | 1 |
| Langella, S | 1 |
| De Simone, R | 1 |
| Leor, J | 1 |
| Levartowsky, D | 1 |
| Sharon, C | 1 |
| Farfel, Z | 1 |
| Cruickshank, JM | 1 |
| Higgins, TJ | 1 |
| Pennert, K | 1 |
| Thorp, JM | 1 |
| Zacharias, FM | 1 |
| Zacharias, FJ | 1 |
1 review available for atenolol and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
[Right ventricular involvement in hypertrophic cardiomyopathy. A case report and brief review of the literature].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Cardiomyopathy, Hypertrophic; Echocar | 2004 |
3 trials available for atenolol and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Atenolol; Biomarkers; Cardiomyopathy, Hypertr | 2020 |
Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy.
Topics: Animals; Anti-Arrhythmia Agents; Atenolol; Cardiomyopathy, Hypertrophic; Cat Diseases; Cats; Drug Ad | 2013 |
Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Cardiomyopathy, Hyp | 2015 |
11 other studies available for atenolol and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Atrial Function, Left; Atrial Remodeling; | 2020 |
End-stage hypertrophic cardiomyopathy in a cat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Atenolol; Benzazepines; C | 2015 |
Atenolol and survival in cats with asymptomatic hypertrophic cardiomyopathy.
Topics: Animals; Asymptomatic Diseases; Atenolol; Cardiomyopathy, Hypertrophic; Cat Diseases; Cats; Male; Su | 2016 |
Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Aged; Anemia, Hemolytic; Anti-Arrhythmia Agents; Atenolol; Cardiomyopathy, Hypertrophic; Echocardiog | 2010 |
Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Cardiomyopathy, Hypertrophic; Defibrillato | 2008 |
Cardiac memory: a mechanical and electrical phenomenon.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Cardiomyopathy, Hypertrophic; | 1997 |
Apical hypokinesis in a patient with hypertrophic cardiomyopathy and myocardial bridging: reversal with beta-blockade--a case report.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cardiomyopathy, Hypertrophic; Coronary Disease; Humans | 1999 |
Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Cardiomyopathy, Hypertrophic; Coronary Disease; Drug Hyperse | 1991 |
[Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle
Topics: Adult; Aged; Atenolol; Cardiomyopathy, Hypertrophic; Chlorthalidone; Diastole; Drug Evaluation; Drug | 1989 |
Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol.
Topics: Amiodarone; Atenolol; Bradycardia; Cardiomyopathy, Hypertrophic; Drug Interactions; Drug Therapy, Co | 1988 |
The efficacy and tolerability of antihypertensive treatment based on atenolol in the prevention of stroke and the regression of left ventricular hypertrophy.
Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Cardiomyopathy, Hypertrophic; Cerebrovascular Dis | 1987 |